Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery
Status:
Completed
Trial end date:
2023-01-06
Target enrollment:
Participant gender:
Summary
This is a single-center, double-blind, randomized controlled trial (RCT) comparing two groups
of application of topical dose of tranexamic acid (TxA) versus placebo in patients undergoing
coronary artery bypass graft (CABG), off pump coronary bypass graft cardiac surgery (OPCAB),
and adult heart valve surgery. The primary outcomes of this study comprised of two
parameters; post operative bleeding and blood product transfusion. The primary outcomes were
assessed during the operation, until 48-hour post operative.